BioMarin Pharmaceutical, Inc. (BMRN)

64.08 +0.66 (+1.04%) USD  |  NASDAQ  |  Feb 20, 16:00
64.00 -0.08 (-0.12%) After-Hours: 20:00
More

BioMarin Pharmaceutical Long Term Deferred Tax Liabilities (Quarterly)

Long Term Deferred Tax Liabilities (Quarterly) Chart

View Long Term Deferred Tax Liabilities (Quarterly) for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Liabilities (Quarterly) Benchmarks

View Long Term Deferred Tax Liabilities (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Gilead Sciences, Inc. --
Merck & Co., Inc. --
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade